The recent decades have witnessed a steady increase in the prevalence of anxiety disorders globally. In Western Europe, anxiety is the most common psychiatric condition. Over the last 50 years, this disorder has tended to be younger, with an average age of patients reducing from 40-50 years to 20-30 years.

Most anxiety disorders are associated with somatic manifestations, namely: palpitations, blood pressure fluctuations, shortness of breath, sweating, chills, intestinal disorders, abdominal pain and urinary frequency. More than half of patients with ischemic heart disease, arterial hypertension, neurocirculatory asthenia have certain signs of anxiety disorders. Chronic anxiety and stress form a perfect background for the development of concomitant disorders both in young people and in the elderly, so-called stress-induced diseases.

In 2018, Nutrimed launched the production of ANXIOMEDIN® that is intended for an active life free from anxiety and stress. ANXIOMEDIN® has a pronounced anxiolytic effect, relieves the negative effects of stress in the body, improves mental alertness and work productivity.

Learn more